Lead researcher Jin Hokyung said, "Our study identified the nasopharyngeal lymphatic plexus as a hub for CSF outflow. CSF ...

Researchers from Taiwan have recently published the results of a study on preradiotherapy imaging for nasopharyngeal carcinoma (NPC). To the authors' knowledge, this is the first study of this ...

therapy in combination with radiotherapy is an effective treatment for late-stage nasopharyngeal carcinoma (NPC). The authors conclude that radiotherapy combined with intratumoral administration ...

Considering taking supplements to treat nasopharyngeal cancer? Below is a list of common natural remedies used to treat or reduce the symptoms of nasopharyngeal cancer. Follow the links to read ...

Dr Reddy's Laboratories on Thursday said it has launched Toripalimab, a drug for the treatment of recurrent or metastatic ...

Dr Reddy’s Laboratories launches Toripalimab, the first immuno-oncology drug for nasopharyngeal carcinoma, in India. Toripalimab, a PD-1 inhibitor, provides a new treatment option for this rare ...

“The launch of Toripalimab is a significant milestone for patients diagnosed with nasopharyngeal carcinoma (NPC) in India. NPC is a rare form of head and neck cancer. However, the prognosis of ...

New Delhi, Nov 28 (PTI) Dr Reddy's Laboratories on Thursday said it has launched Toripalimab, a drug for the treatment of recurrent or metastatic nasopharyngeal carcinoma in India. Nasopharyngeal ...

Dr. Reddy's entered into a licensing and commercialization agreement with Shanghai Junshi Biosciences for toripalimab.